Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
- PMID: 32980319
- PMCID: PMC7508521
- DOI: 10.1016/j.jped.2020.08.007
Extrapulmonary manifestations of COVID-19 in children: a comprehensive review and pathophysiological considerations
Abstract
Objective: The aim of this review was to summarize the most common extrapulmonary manifestations in pediatric patients with COVID-19, as well as to discuss clinical, epidemiological, and pathophysiological aspects of these clinical presentations in children.
Source of data: An extensive search of literature was performed in order to identify pediatric cases with extrapulmonary manifestations between January 1, 2020 and June 21, 2020. Generic keywords, such as "Novel coronavirus" or "Novel coronavirus 2019" or "2019 nCoV" or "COVID-19" or "SARS-CoV-2" were searched on PubMed database, associated either with age filters or generic pediatric terms.
Summary of findings: A total of 28 articles, including 199 patients, were considered suitable to review and data extraction. The main findings were summarized in tables. The main non-pulmonary manifestations in pediatric patients, in decreasing order of frequency, were gastrointestinal, renal, cardiovascular, neurological, hematological and lymphatic, cutaneous, hepatic, ocular, olfactory, and gustatory. Multisystem impairment and Kawasaki-like disease were also described.
Conclusions: Differences in immune response of children and variations of tissue expression of angiotensin converting enzyme 2, the virus receptor, are likely to influence clinical, epidemiological, and pathophysiological patterns of the disease.
Keywords: COVID-19; Extrapulmonary; Kawasaki like-disease; Multisystemic inflammation; Pediatric; SARS-CoV-2.
Copyright © 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
Figures



Similar articles
-
Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review.Curr Pediatr Rev. 2021;17(3):162-171. doi: 10.2174/1573396317666210406153302. Curr Pediatr Rev. 2021. PMID: 33823780
-
COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner.World J Pediatr. 2022 Jun;18(6):373-382. doi: 10.1007/s12519-022-00550-4. Epub 2022 Apr 27. World J Pediatr. 2022. PMID: 35476245 Free PMC article. Review.
-
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.Pediatr Rheumatol Online J. 2021 Mar 16;19(1):29. doi: 10.1186/s12969-021-00511-7. Pediatr Rheumatol Online J. 2021. PMID: 33726806 Free PMC article.
-
Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review.Eur J Paediatr Neurol. 2022 Mar;37:139-154. doi: 10.1016/j.ejpn.2022.02.003. Epub 2022 Feb 18. Eur J Paediatr Neurol. 2022. PMID: 35287009 Free PMC article. Review.
-
A systematic review and meta-analysis protocol examining the clinical characteristics and epidemiological features of olfactory dysfunction (OD) in coronavirus disease 2019 (COVID-19).Syst Rev. 2021 Mar 11;10(1):73. doi: 10.1186/s13643-021-01624-6. Syst Rev. 2021. PMID: 33691796 Free PMC article.
Cited by
-
Renal manifestations of COVID 19 in children.J Family Med Prim Care. 2022 Jun;11(6):2302-2310. doi: 10.4103/jfmpc.jfmpc_1777_21. Epub 2022 Jun 30. J Family Med Prim Care. 2022. PMID: 36119332 Free PMC article. Review.
-
Immunometabolic Dysregulation at the Intersection of Obesity and COVID-19.Front Immunol. 2021 Oct 19;12:732913. doi: 10.3389/fimmu.2021.732913. eCollection 2021. Front Immunol. 2021. PMID: 34737743 Free PMC article. Review.
-
COVID in Pediatric Age: an opinion paper.Rev Esp Quimioter. 2022 Aug;35(4):333-343. doi: 10.37201/req/012.2022. Epub 2022 Mar 15. Rev Esp Quimioter. 2022. PMID: 35287259 Free PMC article. Review.
-
COVID-19 Infection in Pediatric Patients Presenting to a Tertiary Center in Jordan: Clinical Characteristics and Age-Related Patterns.J Clin Med. 2025 Apr 9;14(8):2577. doi: 10.3390/jcm14082577. J Clin Med. 2025. PMID: 40283407 Free PMC article.
-
RS-5645 attenuates inflammatory cytokine storm induced by SARS-CoV-2 spike protein and LPS by modulating pulmonary microbiota.Int J Biol Sci. 2021 Jul 25;17(13):3305-3319. doi: 10.7150/ijbs.63329. eCollection 2021. Int J Biol Sci. 2021. PMID: 34512148 Free PMC article.
References
-
- Situation Report – 183. World Health Organization. 2020. [cited 21 July 2020]. Available from: https://www.who.int/docs/default-source/wha-70-and-phe/20200721-covid-19... = b3869b3_2.
-
- WHO Director-General’s opening remarks at the media briefing on COVID-19 -. 11 March 2020. World Health Organization. 2020 [cited 22 July 2020]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
-
- Patel S., Rauf A., Khan H., Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother. 2017;94:317–325. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous